Abstract
Background
Glypicans play a role in the growth and metastasis of several human cancers. However, little is known about its function in thyroid cancer. Therefore, this study aimed to investigate the specific functions of glypican 2 (GPC2) in thyroid cancer cells.
Objective
The expression of six glypican family members (GPC1 to GPC6) was detected in different thyroid cancer cell lines. The abnormal expression of GPC2 was confirmed by immunohistochemistry in or around thyroid tumor tissues. It was overexpressed and silenced in highly (TPC1 and FTC-133) and poorly (ARO) differentiated thyroid cancer cell lines, respectively. Subsequently, its role in cell proliferation, apoptosis, migration, and invasion was investigated.
Results
We observed that almost all glypican family members were highly expressed in thyroid cancer cells, and GPC2 expression was higher in poorly differentiated thyroid cancer cell lines than highly differentiated cell lines. The knockdown of GPC2 inhibited cell proliferation, invasion, and migration and promoted apoptosis in the ARO cells, whereas GPC2 overexpression promoted cell proliferation, invasion, and migration and inhibited apoptosis in the TPC1 and FTC-133 cells.
Conclusions
GPC2 is highly expressed in thyroid cancer tissues and regulates cell viability, apoptosis, migration, and invasion.
Similar content being viewed by others
References
Albi E et al (2017) Radiation and thyroid cancer. Int J Mol Sci 18:911
American Cancer Society (2015) Cancer facts & figures, 2015. American Cancer Society, Atlanta
Bosse KR et al (2017) Identification of GPC2 as an oncoprotein and candidate immunotherapeutic target in high-risk neuroblastoma. Cancer Cell 32:295–309
Cabanillas ME, McFadden DG, Durante C (2016) Thyroid cancer. Lancet (Lond, Engl) 388:2783–2795
Capurro M, Martin T, Shi W, Filmus J (2014) Glypican-3 binds to Frizzled and plays a direct role in the stimulation of canonical Wnt signaling. J Cell Sci 127:1565–1575
Couchman JR, Pataki CA (2012) An introduction to proteoglycans and their localization. J Histochem Cytochem 60:885–897
Diana T et al (2017) Performance and specificity of 6 immunoassays for TSH receptor antibodies: a multicenter study. Eur Thyroid J 6:243–249
Fahiminiya S, de Kock L, Foulkes WD (2016) Biologic and clinical perspectives on thyroid cancer. N Engl J Med 375:2306–2307
Fico A, Maina F, Dono R (2011) Fine-tuning of cell signaling by glypicans. Cell Mol Life Sci 68:923–929
Filmus J, Capurro M (2013) Glypican-3: a marker and a therapeutic target in hepatocellular carcinoma. FEBS J 280:2471–2476
Filmus J, Capurro M (2014) The role of glypicans in Hedgehog signaling. Matrix Biol 35:248–252
Filmus J, Capurro M, Rast J (2008) Glypicans. Genome Biol 9:224
Gupta M, Brand M (2013) Identification and expression analysis of zebrafish glypicans during embryonic development. PLoS ONE 8:e80824
Kouvaraki MA et al (2005) RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors. Thyroid 15:531–544
Li L et al (2012) Oncogenic activation of glypican-3 by c-Myc in human hepatocellular carcinoma. Hepatology (Baltimore, MD) 56:1380–1390
Pomin VH, Mulloy B (2018) Glycosaminoglycans and proteoglycans. Pharmaceuticals 11:27
Qiao D, Meyer K, Friedl A (2013) Glypican 1 stimulates S phase entry and DNA replication in human glioma cells and normal astrocytes. Mol Cell Biol 33:4408–4421
Song HH, Filmus J (2002) The role of glypicans in mammalian development. Biochem Biophys Acta 1573:241–246
Theocharis AD, Karamanos NK (2017) Proteoglycans remodeling in cancer: underlying molecular mechanisms. Matrix Biol 75-76:220–259
Williams ED et al (2008) Morphologic characteristics of Chernobyl-related childhood papillary thyroid carcinomas are independent of radiation exposure but vary with iodine intake. Thyroid 18:847–852
Yamanaka K et al (2007) Immunohistochemical study of glypican 3 in thyroid cancer. Oncology 73:389–394
Acknowledgements
This work was supported by the Health Industry Research Management Project of Gansu Province (GWGL2014-18). Author Contributions are as follow: Tao Zhang: experimental implementation, drafting of the paper and critical revision. Yahong Liu: data collection. Xuan Ren: statistical analysis. Zhuanping Wang: literature review. Hongjuan Wang: drafting of the paper, critical revision.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Ethical approval
This study was approved by the ethics committee of Lanzhou University Second Hospital, and written informed consent was obtained from the patients or their guardians before sample collection.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zhang, T., Liu, Y., Ren, X. et al. Glypican 2 regulates cell proliferation and metastasis in thyroid cancer cells. Mol. Cell. Toxicol. 16, 203–209 (2020). https://doi.org/10.1007/s13273-020-00073-x
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13273-020-00073-x